On the road to DSM-V and ICD-11

  • David J. Kupfer
  • Darrel A. Regier
  • Emily A. Kuhl


Development of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) has been ongoing since 1994, though official release will not occur for another 4 years. Potential revisions are being derived from multiple sources, including building on perceived limitations of DSM-IV; broad-based literature reviews; secondary and primary data analyses; and discussions between global members of the mental health community. The current focus on aligning DSM with the International Classification of Diseases-11 (ICD-11) speaks to the importance of creating a unified text that embraces cross-cutting issues of diagnostics, such as developmental, age-related, and cultural phenomena. International discourse is vital to this process and has been fostered by a National Institutes of Health-sponsored conference series on diagnosis-specific topics. From this series, the DSM-V Task Force developed the following set of revision principals to guide the efforts of the DSM-V Work Groups: grounding recommendations in empirical evidence; maintaining continuity with previous editions of DSM; removing a priori limitations on the amount of changes DSM-V may incur; and maintaining DSM’s status as a living document. With work group formation complete, members are currently carrying out the research and revision recommendations proposed during the conference series. Ongoing activities include adding specialized advisors to each work group; completing literature reviews and planning data analyses; and forming study groups to discuss integration of cross-cutting issues (e.g., developmental lifespan factors; formation of diagnostic spectra). The road to DSM-V and ICD-11 has been challenging, but members continue to work diligently in their goal of constructing the most harmonious, scientifically sound, and clinically relevant DSM to date.


ICD-11 DSM-V diagnostic criteria developmental lifespan 


Conflict of interest statement

Dr. Kupfer and Dr. Kuhl have no financial conflicts of interest to declare. Darrel A. Regier, M.D., M.P.H.-The author, as Executive Director of American Psychiatric Institute for Research and Education (APIRE), oversees all federal and industry-sponsored research and research training grants in APIRE but receives no external salary funding or honoraria from any government or industry.


  1. 1.
    A Research Agenda for DSM-V (2002) American Psychiatric Association, WashingtonGoogle Scholar
  2. 2.
    Age, Gender Considerations in Psychiatric Diagnosis (2007) A research agenda for DSM-V. American Psychiatric Association, WashingtonGoogle Scholar
  3. 3.
    Diagnostic Issues in Dementia (2007) Advancing the research agenda for DSM-V. American Psychiatric Association, ArlingtonGoogle Scholar
  4. 4.
    Diagnostic Issues in Substance Use Disorders (2007) Refining the research agenda for DSM-V. American Psychiatric Association, ArlingtonGoogle Scholar
  5. 5.
    Dimensional Approaches in Diagnostic Classification (2008) Refining the research agenda for DSM-V. American Psychiatric Association, WashingtonGoogle Scholar
  6. 6.
    Dimensional Models of Personality Disorders (2006) Refining the research agenda for DSM-V. American Psychiatric Association, WashingtonGoogle Scholar
  7. 7.
    Halbertsma J, Heerkens YF, Hirs WM, de Kleijn-de Vrankrijker MW, Dorine Van Ravensberg CD, Napel HT (2000) Towards a new ICIDH. International classification of impairments, disabilities and handicaps. Disabil Rehabil 22(3):144–156PubMedCrossRefGoogle Scholar
  8. 8.
    Hyman SE (2007) Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 8(9):725–732PubMedCrossRefGoogle Scholar
  9. 9.
    Kraemer HC (2007) DSM categories and dimensions in clinical and research contexts. Int J Methods Psychiatr Res 16(Suppl 1):S8–S15PubMedCrossRefGoogle Scholar
  10. 10.
    Krueger RF, Skodol AE, Livesley WJ, Shrout PE, Huang Y (2007) Synthesizing dimensional and categorical approaches to personality disorders: refining the research agenda for DSM-V Axis II. Int J Methods Psychiatr Res 16(Suppl 1):S65–S73PubMedCrossRefGoogle Scholar
  11. 11.
    Leibenluft E, Rich BA (2008) Pediatric bipolar disorder. Annu Rev Clin Psychol 4:163–187PubMedCrossRefGoogle Scholar
  12. 12.
    Robins E, Guze SB (1970) Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 126(7):983–987PubMedGoogle Scholar
  13. 13.
    Scott KM, Von Korff M, Alonso J, Angermeyer MC, Bromet E, Fayyad J et al (2008) Mental-physical comorbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med 26:1–11CrossRefGoogle Scholar
  14. 14.
    The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 (1996). In: Havard School of Public Health on behalf of the World Health Organization and the World Bank, vol I, Global Burden of Disease and Injury Series, CambridgeGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • David J. Kupfer
    • 1
  • Darrel A. Regier
    • 2
  • Emily A. Kuhl
    • 2
  1. 1.Dept. of Psychiatry, Western Psychiatric Institute and ClinicUniversity of Pittsburgh Medical CenterPittsburghUSA
  2. 2.American Psychiatric Institute for Research and Education and Division of ResearchAmerican Psychiatric AssociationArlingtonUSA

Personalised recommendations